A research letter written by Rutgers researchers warns of the dangers of overprescribing antipsychotic medication to elderly ...

Trazodone is linked to better outcomes among older adults hospitalized with delirium than commonly used antipsychotic medications | Drug Discovery And Development ...

Dr. Kennedy answers the question: 'Antipsychotics For Bipolar Disorder?' — -- Question: How do antipsychotics work, when are they used in the treatment of bipolar disorder, and how does one ...

Dr. Brian Brennan answers the question: 'Antipsychotics For Anxiety Disorders? — -- Question: What are antipsychotics, how do they work, and are they helpful in the treatment of anxiety disorders ...

A large U.S. study suggests that older adults hospitalized with delirium may experience better outcomes when treated with ...

Millions of people worldwide are prescribed antipsychotics every year. While these drugs are effective in treating the symptoms of schizophrenia, they can also have significant side-effects, causing ...

Forbes contributors publish independent expert analyses and insights. Alice G. Walton, PhD is a writer who covers health and mental health. A widely reported new study finds that more kids and teens ...

Antipsychotics have been linked to respiratory failure in a dose-dependent manner among patients with chronic obstructive pulmonary disease (COPD), results of a large observational study show.

NEW YORK — U.S. nursing homes have significantly reduced the use of powerful antipsychotic drugs among their elderly residents, responding to pressure from many directions. Yet advocacy groups insist ...

SCOTTSDALE, Arizona ― Second-generation antipsychotics (SGAs) differ with regard to efficacy and side effect profiles for the treatment of first-episode psychosis, according to the results of a new ...

CINCINNATI — Local nursing homes have been cited for administering antipsychotic drugs to patients who don't need them. One man said it happened to his mother at a senior rehab center in Springfield ...

In response to a generic question about post-market drug surveillance posed during a February 2007 House Energy and Commerce Committee hearing, Dr. David Graham, then associate director of science and ...